~~<i id='267250C3E1'><strike id='267250C3E1'><tt id='267250C3E1'><pre id='267250C3E1'></pre></tt></strike></i>~~

Home» explore» explore

explore

author：knowledge 2025-10-06 16:13:28 Page View：46832

MADRID — Merck is paying billions of dollars to partner with Daiichi Sankyo on a series of cancer drugs, underscoring the excitement around targeted chemotherapy treatments.

The deal includes a $4 billion upfront payment and an additional $1.5 billion over the next two years. Up to $16.5 billion more is on the table depending on the success of the drugs in development.

The announcement on Thursday night in the United States came on the eve of one the cancer field’s biggest annual conferences, the European Society for Medical Oncology Congress, being held this year in Madrid.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： N.Y. state detects polio case, first in the U.S. since 2013
Next article： In Memoriam: Notable people who died in 2023

focus

BioMarin wins approval for gene therapy to treat hemophilia A

AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

Target recalls 2.2 million additional candles due to laceration, burn hazards

1:56ThresholdGlassJarCandlessoldexclusivelybyTarget.U.S.ConsumerProductSafetyCommissionTargethasreca

Guidelines to prevent youth baseball injuries need more muscle

Apitcheratthe2018LittleLeagueWorldSeries.RobCarr/GettyImages“Weallknowthatweareinthemiddleofanepidem

Maui funeral service workers on devastation of fires: 'I'm in shock'

1:00InthisimageobtainedfromtheCountyofMauiinHawaii,showsawildfireinLahaina,onAug.9,2023.Hawaiiwildfi